Dajun Yang

CEO

US·SEC (Form 4)

Ascentage Pharma Group International

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 22 May 2026 for ASCENTAGE PHARMA GROUP INTERNATIONAL. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Dajun Yang: trading record in brief

All filings by Dajun Yang on record concern Ascentage Pharma Group International. In total, 2 filings cover trades dated 21 May 2026.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The record was last updated on 22 May 2026 with an option exercise in Ascentage Pharma Group International. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.